MAPT and Alzheimer disease: Importantly, FC-based models predicted tau PET signal in the Alzheimer’s Disease Neuroimaging Intitative-3 dataset (amyloid-β-positive, n = 211, age 55–90) in tau-elevated but not tau-negative individuals.